Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators (Q43849302)

27 November 2017

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators (English)

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

4 December 2022

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

Personality tests

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

5

J. M. Menchon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

author name string

J. Vallejo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

C. Gasto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

R. Catalan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

A. Bulbena

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829739

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1829739

4 December 2022

publication date

1 March 1991

1 reference

full work available at URL

27 November 2017

https://api.elsevier.com/content/article/PII:016503279190036R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

https://api.elsevier.com/content/article/PII:016503279190036R?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Journal of Affective Disorders

4 December 2022

published in

1 reference

27 November 2017

21

1 reference

27 November 2017

3

1 reference

27 November 2017

151-162

1 reference

Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group

27 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The dexamethasone suppression test as a predictor of antidepressant response

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The family history method using diagnostic criteria. Reliability and validity

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Dexamethasone suppression test as a predictor of drug treatment response

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Prediction of tricyclic antidepressant response: a critical review

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Response to dexamethasone and subtype of depression

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The Comparative Antidepressant Value of L-Tryptophan and Imipramine With and Without Attempted Potentiation by Liothyronine

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Does the dexamethasone suppression test predict antidepressant treatment success?

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The dexamethasone suppression test and ECT outcome: a six-month follow-up

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

DSM-III melancholia and the primary-secondary distinction: a comparison of concurrent validity by means of the dexamethasone suppression test.

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Predictors of amitriptyline response in outpatient depressives

4 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression

4 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Dextroamphetamine and dexamethasone suppression test prediction of desipramine response.

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Choice of antidepressant based on the dexamethasone suppression test

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Comparison of pharmacological treatment response between situational and non-situational depressions

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The usefulness of DST in predicting response to antidepressants: a placebo-controlled study

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Dexamethasone suppression test and selection of antidepressant medications

4 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

A rating scale for depression

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Psycho-social predictors of chronicity in depressed patients

4 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The dexamethasone suppression test and prediction of outcome in patients receiving ECT

4 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Prognostic Factors in Treatment of Depressive States with Imipramine

4 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Possible role of antidepressants in precipitating mania and hypomania in recurrent depression

4 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Life events and response to antidepressants

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study

4 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Life events and the endogenous-nonendogenous distinction in the treatment and posttreatment course of depression

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Predicting the response of depressed patients to biological treatment: the dexamethasone suppression test versus clinical judgement

4 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Social support and long-term lithium outcome

4 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Predicting improvement in patients with non-endogenous depression

4 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Life events, depressive relapse and maintenance treatment

4 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Effects of thyrotropin-releasing hormone in depression

4 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

A model for drug use with depressed patients.

4 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

DIFFERENT POPULATIONS, DIFFERENT DRUG RESPONSES. A COMPARATIVE STUDY OF TWO ANTI-DEPRESSANTS, EACH USED IN TWO DIFFERENT PATIENT GROUPS

4 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Marital disputes and treatment outcome in depressed women

4 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Assessing the impact of life changes: development of the Life Experiences Survey

4 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Major depression in the elderly: DSM-III criteria and the dexamethasone suppression test as predictors of treatment response

4 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?

4 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

The short-term outcome of neurotic disorders in the community: the relation of remission to clinical factors and to "neutralizing' life events

4 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders

4 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Clomipramine-Induced Mania in Unipolar Depression

4 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Can antidepressants cause mania and worsen the course of affective illness?

4 December 2022

60

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

Potentiation of Amitriptyline by Thyroid Hormone

4 December 2022

62

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

A SELF-RATING DEPRESSION SCALE

4 December 2022

64

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90036-R

4 December 2022

Identifiers

1 reference

27 November 2017

1 reference